3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases
AssigneeRichter Gedeon Nyrt.
InventorsGeorg Schramm, Christa Kneip
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of 3β-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3β-ol-20-one) and/or 3α-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3α-ol-20-one) for producing a medicament for treating skin, preferably human skin by means of topical application, and to a pharmaceutical or cosmetic composition containing 3β-hydroxychlormadinone acetate and/or 3α-hydroxychlormadinone acetate.
Claims25
A pharmaceutical composition for treating the skin by means of topical application, comprising 0.01 to 20 wt. % of 3β-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3β-ol-20-one) or 3α-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3α-ol-20-one), or mixtures thereof and at least one pharmaceutically acceptable vehicle wherein the composition is formulated as a cream, ointment, lotion, gel, tincture, mask, facial lotion, hair balsam, hair conditioner, hair gel, hair tonic, hair lotion, hair cream or hair shampoo.
A cosmetic composition for care of the skin by topical application comprising 0.01 to 5 wt. % of 3β-hydroxychlormadinone acetate or 3α-hydroxychlormadinone acetate or mixtures thereof and at least one cosmetic vehicle wherein the composition is formulated as a cream, ointment, lotion, gel, tincture, mask, facial lotion, hair balsam, hair conditioner, hair gel, hair tonic, hair lotion, hair cream or hair shampoo.
Dependencies are inferred from the claim text.